NRD
PBH icon

Nebula Research & Development’s Prestige Consumer Healthcare PBH Stock Holding History

Nebula Research & Development’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,325
Closed -$1.14M – 632
2025
Q2 		$1.14M Sell
14,325
-1,346
-9% -$113K 0.1% 354
2025
Q1 		$1.35M Buy
15,671
+12,429
+383% +$1.02M 0.12% 271
2024
Q4 		$253K Sell
3,242
-350
-10% -$27.2K 0.03% 750
2024
Q3 		$259K Buy
+3,592
New +$254K 0.03% 760

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Nebula Research & Development's PBH Position: Q3 2025 in Review

Nebula Research & Development sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 14,325 shares — an estimated $1.14M sold.

Nebula Research & Development first reported a position in PBH in Q3 2024 and held it in 4 quarters. The position peaked at $1.35M in Q1 2025. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Nebula Research & Development reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 14,325 Prestige Consumer Healthcare shares in Q3 2025, an estimated $1.14M.
  • Nebula Research & Development first reported a position in Prestige Consumer Healthcare in Q3 2024 and held it in 4 quarters.
  • Nebula Research & Development's Prestige Consumer Healthcare position peaked at $1.35M in Q1 2025.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.